Clinical Trials Logo

Filter by:
NCT ID: NCT04223661 Withdrawn - Multiple Myeloma Clinical Trials

Frailty Score-guided Dosing of Lenalidomide, Dexamethasone and Daratumumab Induction Therapy

Start date: December 6, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if using a subject's baseline frailty score to guide the dosing of lenalidomide in a combination with dexamethasone and daratumumab (DRd lite).

NCT ID: NCT04223011 Withdrawn - Clinical trials for Alcohol Use Disorder

Initiating Substance Use Disorder Treatment for Hospitalized Alcohol Use Disorder Patients

ISTAP
Start date: March 1, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the impact of a manualized in-hospital recovery coach intervention on rates of post-discharge treatment retention and alcohol use among hospitalized patients with alcohol use disorder.

NCT ID: NCT04221256 Withdrawn - Stroke, Ischemic Clinical Trials

Dose-finding Study of Selective Serotonin Reuptake Inhibitors to Enhance Neuroplasticity

Start date: March 11, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

The brain is able to change throughout life in response to learning, or injury, or to adapt to changes in the environment, which is known as neuroplasticity. Stroke survivors suffer disabling chronic motor impairments that have proven challenging to improve. Increasing neuroplasticity using selective serotonin reuptake inhibitors (SSRIs) is a promising approach to promote motor recovery in patients with stroke.

NCT ID: NCT04220892 Withdrawn - High Grade Glioma Clinical Trials

Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma

Start date: July 8, 2020
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to evaluate any preliminary evidence of anticancer activity of pembrolizumab combined with either pemetrexed or abemaciclib when used following surgery and before standard therapy with radiation and temozolomide in patients with newly diagnosed high grade glioma. Additional aims of the study are to: - Find out the side effects (good and bad) of pembrolizumab combined with pemetrexed or abemaciclib; - • Evaluate tumor characteristics by collecting brain tumor tissue samples. - Measure the amount of pembrolizumab, pemetrexed, and/or abemaciclib that gets in the body by collecting blood and cerebrospinal fluid. - Look at biomarkers (biochemical features that can be used to measure the progress of disease or the effects of a drug) in blood and cerebrospinal fluid if available.

NCT ID: NCT04220502 Withdrawn - Clinical trials for Pseudofolliculitis Barbae

Magic Shave Powder Gold's Affects on the Occurrence of Pseudofolliculitis Barbae

Start date: August 1, 2020
Phase: Early Phase 1
Study type: Interventional

Comparing the amount of papules, macules, pustules, and irritation caused by pseudofolluculitis barbae in subjects using depilatory cream versus traditional shaving methods.

NCT ID: NCT04219501 Withdrawn - Clinical trials for Ventricular Tachycardia

Ventricular Arrhythmia Ablation With the Use of Non-Invasive ECG Imaging Technology

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

Researchers are trying to determine if the use of software called VIVO, made by Catheter Precision, Inc. can shorten the length of time it takes to perform an ablation procedure for either premature ventricular contractions (PVCs) and ventricular tachycardia (VT).

NCT ID: NCT04217707 Withdrawn - Clinical trials for Gender Dysphoria in Adolescents and Adults

Transgender Therapeutic Support Groups

Start date: January 2023
Phase: N/A
Study type: Interventional

This study seeks to explore the effects for transgender people undergoing surgical interventions of participating in pre/post-surgical therapeutic support groups in order to assess the value of adding these programs to hospital systems that are offering gender-affirming surgeries. Participation in either therapeutic support group is expected to increase subjective well-being, increase perceived social support, and decrease clinically significant mental health symptoms compared to participants' baseline scores. It is expected that perceived social support will mediate the relation between group participation and improved subject well-being and mental health scores. In addition, participation in the post-surgical therapeutic support group is expected to reduce the average number of emergency department visits for participants in the group compared with transgender patients, post-gender-affirming surgery, in the hospital as a whole.

NCT ID: NCT04216797 Withdrawn - Clinical trials for Levator Ani Syndrome

Rectal Versus Oral Diazepam Administration in the Treatment of Levator Ani Syndrome

Start date: January 9, 2020
Phase: Phase 4
Study type: Interventional

This research involves collecting data about levator ani syndrome (LAS) associated rectal pain and a comparison of diazepam treatment administration routes. The goal of this research is to see if an alternative route of diazepam administration provides sufficient control of LAS discomfort and low sleep quality while minimizing systemic effects of diazepam (drowsiness).

NCT ID: NCT04216303 Withdrawn - Diabetes Clinical Trials

Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus

Start date: September 12, 2019
Phase:
Study type: Observational

Major cardiovascular events are greatest in liver transplant recipients with sustained post-transplantation diabetes1. However, the optimal A1c target after transplantation has not been studied. The objective is to understand the optimal A1c target post liver and combined liver and kidney transplant. Strict A1c control will improve mortality and cardiovascular risk post liver and combined liver and kidney transplant and improve complications post liver and combined liver and kidney transplant.

NCT ID: NCT04214002 Withdrawn - Clinical trials for Dystrophic Epidermolysis Bullosa

The Natural History of Wounds in Patients With Dystrophic Epidermolysis Bullosa (DEB)

Start date: January 2020
Phase:
Study type: Observational

This study is a non-interventional, observational study that will evaluate the natural history of wounds in patients with Dystrophic Epidermolysis Bullosa (DEB) for inclusion into the Krystal Biotech Phase III protocol of B-VEC (previously KB103). Wound recurrence and wound size will be evaluated for up to four months.